Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in obese rats

Area of Science:

• Cardiovascular Pharmacology
• Endocrinology
• Biochemistry

Background:

• 3,4-Dihydroxyacetophenone (DHAP) exhibits known cardiovascular effects.
• Obesity is associated with impaired endothelial function.
• Endothelial dysfunction contributes to cardiovascular disease.

Purpose of the Study:

• To investigate the effects of DHAP on endothelial function in a rat model of obesity.
• To elucidate the molecular mechanisms underlying DHAP's potential benefits.

Main Methods:

• Wistar rats were fed high-fat diets with or without DHAP for 8 weeks.
• Endothelial-dependent vasodilatation was assessed.
• Key markers of endothelial function, oxidative stress, and inflammation were measured, including nitric oxide (NO) production, eNOS activity, NF-κB activation, and superoxide production.

Main Results:

• DHAP treatment significantly improved endothelial-dependent vasodilatation in obese rats.
• DHAP reduced plasma triglycerides, free fatty acids, TNF-α, and malondialdehyde.
• DHAP increased adiponectin levels, enhanced eNOS activity and NO production, while decreasing NF-κB activation and superoxide production.

Conclusions:

• DHAP effectively improves endothelial function in obese rats.
• The beneficial effects of DHAP are linked to the upregulation of the eNOS-NO pathway.
• DHAP mitigates obesity-induced endothelial dysfunction by improving lipid metabolism, reducing oxidative stress, and suppressing inflammation.